Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum IMV Inc IMVIF

Healthcare Biotechnology
IMV Inc. is a Canada-based company. The Company has no business operations.

Bullboard (GREY:IMVIF)

View:
Prev 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 ... Next
Post by Breakthorough1on Aug 09, 2023 6:51am

The debt

That's what they had to pay to Horizon: 2023: $47.000 2024: $15,302.000 2025: $9,749.000 Nothing for ACOA's debt. Why didn't they try to reach december (ASH meeting)?
147
Discussion
Comment by Jthom376on Aug 06, 2023 7:08am

RE:RE:RE:RE:I guess the SEC should know this

I anticipate a case will be made - and like VXRT, I expect we will end up with a letter in the mail from a law firm.  But if they are bankrupt... is there anything left? 
124
Discussion
Comment by Breakthorough1on Aug 05, 2023 2:35pm

RE:RE:RE:I guess the SEC should know this

This case stated that a statement can contain forward-looking and not forward-looking elements (as perhaps this case, but here the forward-looking statement relies on a historical fact, ie, they ...more  
129
Discussion
Comment by Breakthorough1on Aug 05, 2023 2:20pm

RE:RE:I guess the SEC should know this

Combined with this. March 16th too: "We are targeting a full disclosure of the data in the third quarter. We have enough data in hand to be confident about the direction that, that’s pointing ...more  
102
Discussion
Comment by Breakthorough1on Aug 05, 2023 2:02pm

RE:I guess the SEC should know this

Don't think it is covered by this. They said they had the money to the moment they could see data. March 16th too. "During this call, we will discuss our business outlook and make forward ...more  
97
Discussion
Post by Breakthorough1on Aug 05, 2023 1:41pm

I guess the SEC should know this

March 16th:   "In December, we raised $9 million, which brought our December 31 cash to $21.2 million. This cash takes us into the second half of 2023 and will allow us to see through ...more  
227
Discussion
Post by Breakthorough1on Aug 05, 2023 12:43pm

And SEC link

https://www.sec.gov/tcr
126
Post by Breakthorough1on Aug 05, 2023 10:17am

SEC/FDA and misleading statements about data

"The bad news: Failing to properly disclose material events regarding clinical trial data may result in more than harm to company’s reputation. It could lead to an investigation by the SEC and/or ...more  
147
Post by Breakthorough1on Aug 05, 2023 9:19am

Non-disclosed data

    1- COVID (28-Dic-2020: "We are encouraged by the data generated thus far. Results are consistent with the mechanism of action of our DPX delivery platform demonstrated across ...more  
152
Post by Breakthorough1on Aug 03, 2023 2:28pm

Anyone sending a "Proof of claim"?

"Shareholders and creditors are reminded that in accordance with the Company’s CCAA proceedings, there is an ongoing claims process and they are encouraged to carefully review the information ...more  
145
Post by Breakthorough1on Aug 03, 2023 12:30pm

November 11 2022

"As a result of our recent reorganization and cost reduction measures, we expect our 2023 average cash burn per quarter to remain consistent with 2022, despite forecasted increases in clinical ...more  
114
Post by Breakthorough1on Aug 01, 2023 12:27pm

Armistice and Vaxart

"Shareholders of Covid-19 vaccine developer Vaxart Inc. adequately stated insider trading and scheme participation claims against Armistice Capital LLC, a hedge fund linked to Vaxart, a federal ...more  
129
Post by antigua1987on Jul 31, 2023 10:16am

Hope for less younger employees of IMV

People like the curr cfo (or whatever title she has) hopefully will be able to shake the absolute slime induced leadership of the more experienced grinders with whom they crossed paths. Even the most ...more  
160
Post by Breakthorough1on Jul 30, 2023 7:13am

Misleading and forward-looking statements

"The class plaintiffs alleged that statements, including those claiming that production of the Model 3 was “on track,” and “coming in as expected, that there “were no issues,” and that 50 ...more  
209
Comment by Breakthorough1on Jul 29, 2023 4:16pm

RE:Pantginis and Armistice

I mean February 13 (the dsy of the data), sorry: https://markets.businessinsider.com/news/stocks/analysts-offer-insights-on-healthcare-companies-imv-imv-and-siemens-healthineers-ag-othersemhf ...more  
97
Discussion
Prev 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 ... Next
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Dealroom for high-potential pre-IPO opportunities